Why MDxHealth (MDXH) Stock Is Up Today

MDxHealth (MDXH) is up 86.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The sharp move appears tied to MDxHealth’s second-quarter 2026 update, which showed 16% year-over-year revenue growth, improving sequential sales, and management’s view that the company remains on track to meet or exceed full-year guidance. Investors also may be responding to the company’s newly strengthened cash position after a $20 million registered direct share sale and to the cleaner strategic focus created by shutting down the non-core Resolve business.

Details:

Second-quarter revenue rose to $27.2 million, up 16% from a year earlier, while sales increased by $3.3 million from the first quarter.

Management said the transition of Resolve customers was completed by June 30 and pointed to recovery in the tissue-based testing business, with tissue test volume up 13% sequentially.

MDxHealth said it still expects 2026 revenue of $110 million to $115 million and sees a return to positive adjusted EBITDA as it exits the year.

The company disclosed a registered direct placement of about 44.1 million shares for gross proceeds of $20 million, lifting pro forma cash to about $39.2 million, while the Resolve wind-down moved Delta Lab into an assignment process tied to a previously disclosed reimbursement recoupment claim.

Sources:

mdxhealth, SEC, Nasdaq

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$MDXH Hedge Fund Activity

We have seen 20 institutional investors add shares of $MDXH stock to their portfolio, and 35 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

SAMJO MANAGEMENT, LLC removed 1,449,450 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $595,144
MINK BROOK ASSET MANAGEMENT LLC added 940,034 shares (+356.9%) to their portfolio in Q1 2026, for an estimated $2,162,078
NORTHERN TRUST CORP removed 494,523 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $203,051
MILLENNIUM MANAGEMENT LLC added 427,897 shares (+366.3%) to their portfolio in Q1 2026, for an estimated $984,163
GSA CAPITAL PARTNERS LLP added 411,089 shares (+579.8%) to their portfolio in Q2 2026, for an estimated $168,793
FREEGULLIVER LLC removed 317,894 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $731,156
SQUAREPOINT OPS LLC added 200,281 shares (+inf%) to their portfolio in Q2 2026, for an estimated $82,235

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$MDXH Price Targets

Multiple analysts have issued price targets for $MDXH recently. We have seen 3 analysts offer price targets for $MDXH in the last 6 months, with a median target of $4.0.

Here are some recent targets:

Mark Massaro from BTIG set a target price of $4.0 on 05/14/2026
Dan Brennan from TD Cowen set a target price of $1.5 on 05/14/2026
Thomas Flaten from Lake Street set a target price of $5.0 on 05/14/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.